NO20004648L - Nukleinsyreoverføringsvektorer, deres anvendelse samt preparater inneholdende vektorene - Google Patents

Nukleinsyreoverføringsvektorer, deres anvendelse samt preparater inneholdende vektorene

Info

Publication number
NO20004648L
NO20004648L NO20004648A NO20004648A NO20004648L NO 20004648 L NO20004648 L NO 20004648L NO 20004648 A NO20004648 A NO 20004648A NO 20004648 A NO20004648 A NO 20004648A NO 20004648 L NO20004648 L NO 20004648L
Authority
NO
Norway
Prior art keywords
vectors
nucleic acid
preparations containing
acid transfer
transfer vectors
Prior art date
Application number
NO20004648A
Other languages
English (en)
Other versions
NO20004648D0 (no
Inventor
Carole Ciolina
Daniel Scherman
Pierre Wils
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9803573A external-priority patent/FR2776669B1/fr
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20004648D0 publication Critical patent/NO20004648D0/no
Publication of NO20004648L publication Critical patent/NO20004648L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20004648A 1998-03-24 2000-09-18 Nukleinsyreoverføringsvektorer, deres anvendelse samt preparater inneholdende vektorene NO20004648L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9803573A FR2776669B1 (fr) 1998-03-24 1998-03-24 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations
US8584898P 1998-05-18 1998-05-18
PCT/FR1999/000643 WO1999049067A1 (fr) 1998-03-24 1999-03-19 Vecteurs de transfert d'acides nucleiques, compositions les contenant, et leurs utilisations

Publications (2)

Publication Number Publication Date
NO20004648D0 NO20004648D0 (no) 2000-09-18
NO20004648L true NO20004648L (no) 2000-09-18

Family

ID=26234216

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004648A NO20004648L (no) 1998-03-24 2000-09-18 Nukleinsyreoverføringsvektorer, deres anvendelse samt preparater inneholdende vektorene

Country Status (12)

Country Link
EP (1) EP1066396A1 (no)
JP (1) JP2002507429A (no)
KR (1) KR20010074456A (no)
CN (1) CN1292827A (no)
AU (1) AU758406B2 (no)
BR (1) BR9909044A (no)
CA (1) CA2323831A1 (no)
HU (1) HUP0102413A3 (no)
IL (1) IL138624A0 (no)
NO (1) NO20004648L (no)
PL (1) PL342944A1 (no)
WO (1) WO1999049067A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4803945B2 (ja) * 2000-05-26 2011-10-26 アバンテイス・フアルマ・エス・アー 固定化オリゴヌクレオチドを使用する三重らせん形態の精製
FR2871465B1 (fr) * 2004-06-15 2006-09-08 Centre Nat Rech Scient Cnrse Collections de composes tracables et leurs utilisations
US7943589B2 (en) 2005-06-03 2011-05-17 President And Fellows Of Harvard College siRNA microbicides for preventing and treating diseases
US7795380B2 (en) 2006-06-02 2010-09-14 University Of Iowa Research Foundation Compositions and methods for nucleic acid delivery
EP3427054B1 (en) * 2016-03-07 2025-01-08 Quidel Cardiovascular Inc. Immunoassay controls and the use thereof
RU2731513C2 (ru) * 2018-12-21 2020-09-03 Селл энд Джин Терапи Лтд Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
CN120936386A (zh) * 2023-03-24 2025-11-11 艾德赛瑞思股份有限公司 核定位多肽及其缀合物及其用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020698A1 (en) * 1991-05-17 1992-11-26 Uab Research Foundation Sequence specific dna binding drugs
US5670347A (en) * 1994-05-11 1997-09-23 Amba Biosciences Llc Peptide-mediated gene transfer
FR2731014B1 (fr) * 1995-02-23 1997-03-28 Rhone Poulenc Rorer Sa Molecules d'adn, preparation et utilisation en therapie genique

Also Published As

Publication number Publication date
AU758406B2 (en) 2003-03-20
IL138624A0 (en) 2001-10-31
EP1066396A1 (fr) 2001-01-10
PL342944A1 (en) 2001-07-16
WO1999049067A1 (fr) 1999-09-30
NO20004648D0 (no) 2000-09-18
CN1292827A (zh) 2001-04-25
HUP0102413A3 (en) 2003-09-29
CA2323831A1 (fr) 1999-09-30
KR20010074456A (ko) 2001-08-04
BR9909044A (pt) 2000-12-05
AU3406200A (en) 2000-12-14
JP2002507429A (ja) 2002-03-12
HUP0102413A1 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
NO20010013D0 (no) Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
NO996269D0 (no) Quinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
DK0918059T3 (da) Susbstituerede imidazolidinderivater, deres fremstilling og anvendelse samt farmaceutiske præparater indeholdende disse derivater
NO308287B1 (no) Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse
NO20016247L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene
DK1109450T3 (da) Mikrokapselpræparater
HUP0104825A3 (en) Genes and proteins, and their use
NO306060B1 (no) Substituerte kanelsyreguanidider, deres anvendelse samt medikamenter inneholdende guanididene
NO963487D0 (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
NO20004648D0 (no) Nukleinsyreoverføringsvektorer, deres anvendelse samt preparater inneholdende vektorene
NO20003074L (no) Immunoglobolinrik melk, fremstilling samt anvendelse derav
FI940923A7 (fi) Nukleiinihappopolymeraasin tehostaminen
DE69835955D1 (de) TEMPERATUR-EMPFINDLICHE dtsR GENE
FI902803A7 (fi) DNA-sekvenssi, joka koodaa a-amylaasi-pullulanaasientsyymiä
NO995948D0 (no) DNA-sekvenser, ekspresjon av disse DNA-sekvenser, termofile laccaser kodet for av DNA-sekvensene, samt anvendelse av disse
DE59912375D1 (de) Retrovirale Gentransfervektoren
NO20012684D0 (no) Nye nukleinsyre-overföringsmidler, preparater inneholdende disse, samt deres anvendelse
NO20004780L (no) Nye overføringsmidler for nukleinsyrer, preparater inneholdende disse samt midlenes anvendelse
NO20020404L (no) Streptograminderivater, deres fremstilling samt preparater inneholdende derivatene
MX9204348A (es) Vector de adn para la transformacion de celulas de bacillus thuringiensis.
PL343000A1 (en) Novel sequence class of genes, corresponding proteins and the use of the same
AU5877601A (en) Polypeptide derivatives and nucleic acid carriers containing the same
EE03645B1 (et) Edastuskiiruse sobitus
AP2005003413A0 (en) Genes and proteins, and their use.
ITBO970308A0 (it) Sistema di lotta biologica integrata antimuscidica.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application